AZ Delta (Campus Rumbeke)
About AZ Delta (Campus Rumbeke)
"AZ Delta is een ziekenhuis met campussen in Rumbeke, Roeselare, Menen en Torhout. In Menen en Torhout is een goed uitgebouwde basiszorg aanwezig. Voor meer gespecialiseerde behandelingen en ingrepen wordt doorverwezen naar de hoofdcampus in Rumbeke."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
12
Amgen
3
Idorsia Pharmaceuticals Ltd.
1
Inventiva Pharma
1
Swedish Orphan Biovitrum
1
UNICANCER
1
Clinical Trials at AZ Delta (Campus Rumbeke)
During the past decade, AZ Delta (Campus Rumbeke) conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 5 clinical trials were completed, i.e. on
average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 2 clinical trials were completed. i.e. 25%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple Sclerosis
2011-08-31
2022-12-31
Completed
821
A Study Comparing Vemurafenib Versus Vemurafenib Plus Cobimetinib in Participants With Metastatic Melanoma
2013-01-08
2019-07-21
Completed
495
A Study to Evaluate the Benefit of Venetoclax Plus Rituximab Compared With Bendamustine Plus Rituximab in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
2014-03-17
2022-08-03
Completed
389
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
2014-09-15
2025-08-16
Active, not recruiting
1,822
A Study of Biomarker-Driven Therapy in Metastatic Colorectal Cancer (mCRC)
2015-04-17
2021-03-24
Completed
609
A Study of Idasanutlin With Cytarabine Versus Cytarabine Plus Placebo in Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)
2015-12-30
2020-04-24
Terminated
447
Non-interventional Study of Ocrelizumab in Participants With Relapsing or Primary Progressive Multiple Sclerosis
2018-11-12
2025-07-26
Active, not recruiting
1,700
A Phase 1/2, Study Evaluating the Safety, Tolerability, PK, and Efficacy of Sotorasib (AMG 510) in Subjects With Solid Tumors With a Specific KRAS Mutation (CodeBreaK 100)
2018-08-27
2027-05-09
Active, not recruiting
713
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "AZ Delta (Campus Rumbeke)" #1 sponsor was "Hoffmann-La Roche" with 12 trials, followed by "Amgen" with 3 trials
sponsored, "Idorsia Pharmaceuticals Ltd." with 1 trials sponsored, "Inventiva Pharma" with 1 trials sponsored and "Swedish Orphan Biovitrum"
with 1 trials sponsored. Other sponsors include -4 different institutions and
companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "AZ Delta (Campus Rumbeke)"
#1 collaborator was "AbbVie" with 1 trials as a collaborator, "BioMérieux" with 1 trials as a collaborator, "Cytel Inc." with 1 trials as a collaborator, "Hoffmann-La Roche" with 1 trials as a collaborator and "PRA Health Sciences" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were
collaborators in the rest 5 trials.
Clinical Trials Conditions at AZ Delta (Campus Rumbeke)
According to Clinical.Site data, the most researched conditions in "AZ Delta (Campus Rumbeke)" are
"Small Cell Lung Cancer" (2 trials), "Acute Myocardial Infarction" (1 trials), "Bladder Cancer" (1 trials), "Carcinoma, Hepatocellular" (1 trials) and "Chronic Lymphocytic Leukemia" (1 trials). Many other conditions were trialed in "AZ Delta (Campus Rumbeke)" in a lesser frequency.
Clinical Trials Intervention Types at AZ Delta (Campus Rumbeke)
Most popular intervention types in "AZ Delta (Campus Rumbeke)" are "Drug" (17 trials), "Other" (2 trials), "Combination Product" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (8 trials), "Placebo" (6 trials), "Bevacizumab" (2 trials), "Carboplatin" (2 trials) and "Cobimetinib" (2 trials). Other intervention names were less common.
Clinical Trials Genders at AZ Delta (Campus Rumbeke)
The vast majority of trials in "AZ Delta (Campus Rumbeke)" are
19 trials for "All" genders.
Clinical Trials Status at AZ Delta (Campus Rumbeke)
Currently, there are NaN active trials in "AZ Delta (Campus Rumbeke)".
undefined are not yet recruiting,
6 are recruiting,
6 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 4 completed trials in AZ Delta (Campus Rumbeke),
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in AZ Delta (Campus Rumbeke), 2 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 13 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".